List of Excipients in API conjugated estrogens and medroxyprogesterone acetate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing conjugated estrogens and medroxyprogesterone acetate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| A-S Medication Solutions | PREMPRO | conjugated estrogens and medroxyprogesterone acetate | 50090-0573 | CARNAUBA WAX | |
| A-S Medication Solutions | PREMPRO | conjugated estrogens and medroxyprogesterone acetate | 50090-0573 | CELLULOSE, MICROCRYSTALLINE | |
| A-S Medication Solutions | PREMPRO | conjugated estrogens and medroxyprogesterone acetate | 50090-0573 | FERRIC OXIDE YELLOW | |
| A-S Medication Solutions | PREMPRO | conjugated estrogens and medroxyprogesterone acetate | 50090-0573 | FERROSOFERRIC OXIDE | |
| A-S Medication Solutions | PREMPRO | conjugated estrogens and medroxyprogesterone acetate | 50090-0573 | HYDROXYPROPYL CELLULOSE | |
| A-S Medication Solutions | PREMPRO | conjugated estrogens and medroxyprogesterone acetate | 50090-0573 | HYPROMELLOSE 2208 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for conjugated estrogens and medroxyprogesterone acetate
Excipient focus: CARNAUBA WAX
conjugated estrogens and medroxyprogesterone acetate drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | conjugated estrogens and medroxyprogesterone acetate | 50090-0573 |
| >Company | >Ingredient | >NDC |
conjugated estrogens and medroxyprogesterone acetate drug variants not containing CARNAUBA WAX
Excipient focus: CELLULOSE, MICROCRYSTALLINE
conjugated estrogens and medroxyprogesterone acetate drug variants containing CELLULOSE, MICROCRYSTALLINE
conjugated estrogens and medroxyprogesterone acetate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
conjugated estrogens and medroxyprogesterone acetate drug variants containing FERRIC OXIDE YELLOW
conjugated estrogens and medroxyprogesterone acetate drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
conjugated estrogens and medroxyprogesterone acetate drug variants containing FERROSOFERRIC OXIDE
conjugated estrogens and medroxyprogesterone acetate drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
conjugated estrogens and medroxyprogesterone acetate drug variants containing HYDROXYPROPYL CELLULOSE
conjugated estrogens and medroxyprogesterone acetate drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2208
conjugated estrogens and medroxyprogesterone acetate drug variants containing HYPROMELLOSE 2208
conjugated estrogens and medroxyprogesterone acetate drug variants not containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
conjugated estrogens and medroxyprogesterone acetate drug variants containing HYPROMELLOSE 2910
conjugated estrogens and medroxyprogesterone acetate drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
conjugated estrogens and medroxyprogesterone acetate drug variants containing LACTOSE MONOHYDRATE
conjugated estrogens and medroxyprogesterone acetate drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
conjugated estrogens and medroxyprogesterone acetate drug variants containing MAGNESIUM STEARATE
conjugated estrogens and medroxyprogesterone acetate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
conjugated estrogens and medroxyprogesterone acetate drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
conjugated estrogens and medroxyprogesterone acetate drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
conjugated estrogens and medroxyprogesterone acetate drug variants containing POLYETHYLENE GLYCOL 400
conjugated estrogens and medroxyprogesterone acetate drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
conjugated estrogens and medroxyprogesterone acetate drug variants containing POVIDONE
conjugated estrogens and medroxyprogesterone acetate drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | conjugated estrogens and medroxyprogesterone acetate | 50090-0573 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
conjugated estrogens and medroxyprogesterone acetate drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | conjugated estrogens and medroxyprogesterone acetate | 50090-0573 |
| >Company | >Ingredient | >NDC |
conjugated estrogens and medroxyprogesterone acetate drug variants not containing PROPYLENE GLYCOL
Excipient focus: SUCROSE
conjugated estrogens and medroxyprogesterone acetate drug variants containing SUCROSE
conjugated estrogens and medroxyprogesterone acetate drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
conjugated estrogens and medroxyprogesterone acetate drug variants containing TITANIUM DIOXIDE
conjugated estrogens and medroxyprogesterone acetate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIBASIC CALCIUM PHOSPHATE
conjugated estrogens and medroxyprogesterone acetate drug variants containing TRIBASIC CALCIUM PHOSPHATE
conjugated estrogens and medroxyprogesterone acetate drug variants not containing TRIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links